List of Marijuana/Cannabinoid-Derived Drugs Companies in Canada - 11

Akseera, is a science driven, innovative, and distinctive company that draws on the unique experiences of our team to bring ingenious solutions that address unfulfilled medical needs globally. We endeavor to do this independently and in collaboration with world class institutions to help improve lives.

Outsourcing made easy with a one-stop solution to early phase drug development. We are an integrated drug development solution company, offering pharmaceutical and biotechnology companies a proven, flexible approach that removes the need for multiple service providers during the early stages of drug development. Whether for one study or an end-to-end program, we help you reach critical decision-making milestones sooner by improving speed and ease from lead candidate selection to clinical proof of concept, and beyond. When partnering with Altasciences, you can experience up to 40% in time savings thanks to our integrated, one-stop solution offering. We strive to create a true partnership with our clients, our partners, and our colleagues that enables a mutually supporting relationship built on a combination of excellent science and solid communication. Helping sponsors get better drugs to the people who need them, faster, for over 25 years. Our full-service offering is always tailored to your specific research needs: - Preclinical research - Clinical pharmacology - Drug formulation - Manufacturing and analytical services - Bioanalysis - Program management - Medical writing - Biostatics - Data management - And so much more!

Cardiol Therapeutics Inc. (NASDAQ: CRDL | TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Cardiol has received Investigational New Drug Application authorization from the US FDA to conduct clinical studies to evaluate the efficacy and safety of CardiolRx™ in two diseases affecting the heart: (i) a Phase II multi-center open-label pilot study in recurrent pericarditis (the MAvERIC-Pilot study), an inflammatory disease of the pericardium which is associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, and results in physical limitations, reduced quality of life, emergency department visits, and hospitalizations; and (ii) a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ARCHER trial) in acute myocarditis, an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in people less than 35 years of age. The US FDA has granted Orphan Drug Designation to CardiolRx™ for the treatment of pericarditis, which includes recurrent pericarditis. Cardiol is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure – a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding $30 billion annually.

Dionamix Scientific Inc. is a rapidly evolving company boasting over a decade of expertise in chemical analytical instruments such as an All-In-One Solution for Lipid Nanoparticle Synethsization, HPLC, UV-Vis Spectrometer, Diode Array Detector, Autosampler, and Chromatography Workstation Analytical Software. Specializing in designing and manufacturing IP-rich chromatography and spectroscopy analytical instruments, Dionamix Scientific has a proven track record of over 10 years in delivering innovative products. Our mission is to provide tailored solutions for analytical lab managers, as well as quality and safety-focused professionals in the food, beverage, and natural medicine industries, offering efficient and cost-effective compound analysis. With a global team dedicated to innovation, quality, and exceptional customer service, we strive to optimize solutions for small to medium-scale operations. While you focus on your product, Dionamix specializes in sample separation and analysis, collaborating to unveil crucial details determining the concentrations, quality, and safety of your produce. has context menu

Avant is an industry leader of handcrafted, small-batch, superior quality cannabis products. Our innovation, consistency and commitment to the highest standards have allowed us to continually succeed in a rapidly evolving marketplace. Our forward-thinking consumer-focused brands are setting the stage for future industry trends.

InMed Pharmaceuticals is a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s pipeline consists of three drug development programs in the treatment of Alzheimer’s, ocular and dermatological indications. Together with our subsidiary BayMedica, we are a global leader in the manufacturing, development and commercialization of products based on rare cannabinoids and their proprietary, small molecule drug analogs. For more information, visit www.inmedpharma.com. Nasdaq: INM

Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical, cannabis and hemp industries, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies. From clinical study design to impactful product marketing, KGK has client success down to a science. At our state-of-the-art clinical research facilities, clinical staff, researchers, and regulatory experts quickly turn requests into results. We've guided hundreds of companies in taking their initial product concepts on to clinically proven claims and beyond, working to differentiate ideas and offer unique pathways through complex regulatory bodies including Health Canada, FDA, and FTC. Recognized globally as thought-leaders in cannabinoid science and regulation for the natural health product industry, KGK Science is proudly the first CRO in Canada to possess a Cannabis Research License, extending our 22 years of industry experience to include cannabis and hemp-derived products. As the leading CRO in the cannabis industry, KGK is focused on expertly conducting clinical trials and providing regulatory support to help bring innovative new health products to market, continuing to further global research and unlock the true value of the cannabis industry for clients and consumers.

PreveCeutical Medical Inc. is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products.

Provides standardized dosing through pre-packaged, single-use pods filled with the highest quality cannabis buds or oil

Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations.

Segra is a biotechnology company that specializes in industrial-scale plant micropropagation also known as “plant tissue culture.” The company is developing industrial-scale micropropagation laboratories to produce healthy, robust plantlets for growers and licensed cannabis producers globally. Our solution: Segra leverages expertise in plant tissue culture, biochemistry, botany, genetic testing, and production under strict regulatory environments to bring end-to-end solutions for product production and sale in the agriculture space. Investors: info@segra-intl.com